在COPD急性恶化的住院患者中,血红蛋白稳定性预测了临床结果
Lujia Guan1, Jiachen Li2, Lirong Liang2
1Department of Respiratory and Critical Care Medicine, Beijing Research Center for Respiratory Infectious Diseases, Beijing Institute of Respiratory Medicine and Beijing Chao Yang Hospital, Capital Medical University, Beijing, People's Republic of China.
International journal of chronic obstructive pulmonary disease
|August 28, 2025
概括
慢性阻塞性肺病 (AECOPD) 患者在住院期间血液中乙氨基基基 (EOS) 的稳定性会影响治疗结果. 持续高EOS水平与较少的医院不良事件有关,但未来再入院的风险更高.
科学领域:
- 肺病学
- 临床生物标志物
- 呼吸系统医学
背景情况:
- 血中乙氨基酸水平是治疗慢性阻塞性肺病 (AECOPD) 急性恶化的一个潜在生物标志物.
- 在住院期间EOS稳定性对患者结局的影响尚不清楚.
- 本研究研究了EOS稳定性与AECOPD患者的临床结果之间的关系.
研究的目的:
- 检查慢性阻塞性肺病 (AECOPD) 急性恶化患者住院期间血红蛋白稳定性与临床结果之间的关联.
- 确定EOS稳定性是否可以预测AECOPD患者的不良医院结果和未来再入院风险.
主要方法:
- 在2013年至2022年期间住院的2105名AECOPD患者的回顾性分析.
- 根据入院和出院时的EOS水平,患者被分为四组:持续高,降低,增加和持续低.
- 用多变量逻辑回归,考克斯回归,ROC曲线和名图来分析结果和预测准确性.
主要成果:
- 与持续低EOS组相比,持续高EOS组的医院不良结果风险显著降低 (aOR: 0. 77).
- 开发用于预测医院不良结果的诺米图表显示出很好的准确性 (AUC: 0. 67).
- 与持续低EOS组相比,持续高EOS组在三年内表现出与AECOPD相关的再入院风险较高 (aHR为1. 38).
结论:
- 在住院期间血液中乙素的稳定性与AECOPD的预后有关.
- EOS的稳定性可能有助于指导住院治疗决策.
- 监测EOS稳定性可以帮助识别未来再入院风险较高的AECOPD患者.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
305
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
305
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
COPD: Pathogenesis and Clinical Features
516
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
516
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K


